Laparoscopic radiofrequency ablation of unresectable hepatocellular carcinoma: Long-term follow-up

HPB

Volumn 10, Issue 5, 2008, Pages 315-320

  Ballem, Naveen ^a   Berber, Eren ^a   Pitt, Tracy ^a   Siperstein, Allan ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Hepatocellular cancer; Long term outcomes; Radiofrequency ablation

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; BILIRUBIN;

ADULT; AGE; AGED; ASCITES; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; HUMAN; INTERNATIONAL NORMALIZED RATIO; LAPAROSCOPY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; SURVIVAL RATE; SURVIVAL TIME; TERTIARY HEALTH CARE;

EID: 54549088021     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1080/13651820802247102     Document Type: Conference Paper

References (27)

1. Yamashiki, N., Yoshida, H., Tateishi, R., Shiina, S., Teratani, T. Yoshida, H. et al. (2007) Recurrent hepatocellular carcinoma has an increased risk of subsequent recurrence after curative treatment. J Gastroenterol Hepatol, 22:12, pp. 2155-2160.
2. Parkin, DM, Bray, F., Ferlay, J. and Pisani, P. (2005) Global cancer statistics, 2002. CA Cancer J Clin, 55:2, pp. 74-108.
3. Shiratori, Y., Yoshida, H. and Omata, M. (2001) Management of hepatocellular carcinoma: Advances in diagnosis, treatment and prevention. Expert Rev Anticancer Ther, 1:2, pp. 277-290.
4. Lam, VW, Ng, KK, Chok, KS, Cheung, TT, Yuen, J. Tung, H. et al. (2007) Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma: Analysis of risk factors and prognostic factors. Ann Surg Oncol
5. Takahashi, S., Kudo, M., Chung, H., Inoue, T., Ishikawa, E. Kitai, S. et al. (2007) Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology, 72, pp. 98-103.
6. Berber, E., Herceg, NL, Casto, KJ and Siperstein, AE. (2004) Laparoscopic radiofrequency ablation of hepatic tumors: Prospective clinical evaluation of ablation size comparing two treatment algorithms. Surg Endosc, 18:3, pp. 390-396.
7. Kuehl, H., Stattaus, J., Hertel, S., Hunold, P., Kaiser, G. Bockisch, A. et al. (2007) Mid-term outcome of positron emission tomography/computed tomography-assisted radiofrequency ablation in primary and secondary liver tumours-a single-centre experience. Clin Oncol (R Coll Radiol)
8. Scheele, J., Stang, R., Altendorf-Hofmann, A. and Paul, M. (1995) Resection of colorectal liver metastases. World J Surg, 19:1, pp. 59-71.
9. Yan, K., Chen, MH, Yang, W., Wang, YB, Gao, W. Hao, CY et al. (2007) Radiofrequency ablation of hepatocellular carcinoma: Long-term outcome and prognostic factors. Eur J Radiol
10. Bleicher, RJ, Allegra, DP, Nora, DT, Wood, TF, Foshag, LJ and Bilchik, AJ. (2003) Radiofrequency ablation in 447 complex unresectable liver tumors: Lessons learned. Ann Surg Oncol, 10:1, pp. 52-58.
11. Curley, SA, Izzo, F., Ellis, LM, Nicolas Vauthey, J and Vallone, P. (2000) Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg, 232:3, pp. 381-391.
12. Teratani, T., Yoshida, H., Shiina, S., Obi, S., Sato, S. Tateishi, R. et al. (2006) Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology, 43:5, pp. 1101-1108.
13. Nagasue, N., Kohno, H., Tachibana, M., Yamanoi, A., Ohmori, H. and El-Assal, ON. (1999) Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis. Ann Surg, 229:1, pp. 84-90.
14. El-Serag, HB and Mason, AC. (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med, 340:10, pp. 745-750.
15. Majno, P., Castaing, D., Adam, R., Savier, E., Ghemard, O. and Bismuth, H. (2003) Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: A reasonable strategy?. Ann Surg, 238:4, pp. 508-518.
16. Yamamoto, J., Iwatsuki, S., Kosuge, T., Dvorchik, I., Shimada, K. Marsh, JW et al. (1999) Should hepatomas be treated with hepatic resection or transplantation?. Cancer, 86:7, pp. 1151-1158.
17. Bismuth, H., Majno, PE and Adam, R. (1999) Liver transplantation for hepatocellular carcinoma. Semin Liver Dis, 19:3, pp. 311-322.
18. Befeler, AS and Di Bisceglie, AM. (2002) Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology, 122:6, pp. 1609-1619.
19. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan (1994) The Liver Cancer Study Group of Japan. Cancer, 74:10, pp. 2772-2780.
20. O'Neil, BH and Venook, AP. (2007) Hepatocellular carcinoma: The role of the North American GI steering committee hepatobiliary task force and the advent of effective drug therapy. Oncologist, 12:12, pp. 1425-1432.
21. Guglielmi, A., Ruzzenente, A., Pachera, S., Valdegamberi, A., Sandri, M. D'Onofrio, M. et al. (2007) Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response. Am J Gastroenterol
22. Colombo, M., de Franchis, R., Del Ninno, E, Sangiovanni, A., De Fazio, C. Tommasini, M. et al. (1991) Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med, 325:10, pp. 675-680.
23. Chen, MS, Li, JQ, Zheng, Y., Guo, RP, Liang, HH Zhang, YQ et al. (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg, 243:3, pp. 321-328.
24. Wakai, T., Shirai, Y., Suda, T., Yokoyama, N., Sakata, J. Cruz, PV et al. (2006) Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma
25. Siperstein, AE, Berber, E., Ballem, N. and Parikh, RT. (2007) Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Annals of Surgery, 246:4, pp. 559-565.
26. Llovet, JM and Bruix, J. (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology, 37, pp. 429-442.
27. Lopez, PM, Villanueva, A. and Llovet, JM. (2006) Systematic review: evidence-based management of hepatocellular carcinoma-an updated analysis of randomized controlled trials. Aliment Pharmacol Ther, 23, pp. 1535-1547.